Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate

References

• Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome. JAMA260, 929–934 (1988).
   PubMed Web of Science ®Google Scholar
• Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJ, Wessely SC. Population based study of fatigue and psychological distress. Br. Med. J.308, 763–766 (1994).
   PubMed Web of Science ®Google Scholar
• Bates DW, Schmitt W, Buchwald D et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch. Intern. Med.153, 2759–2765 (1993).
   PubMed Web of Science ®Google Scholar
• McDonald E, David AS, Pelosi AJ, Mann AH. Chronic fatigue in primary care attenders. Psychol. Med.23, 987–998 (1993).
   PubMed Web of Science ®Google Scholar
• Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. Psychol. Med.25, 895–905 (1995).
   PubMed Web of Science ®Google Scholar
• Shorter E. Chronic fatigue in historical perspective. Ciba Found Symp.173, 6–22 (1993).
   PubMedGoogle Scholar
• Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am. J. Psychiatry160, 221–236 (2003).
   PubMed Web of Science ®Google Scholar
• Ranjith G. Epidemiology of chronic fatigue syndrome. Occup. Med. (Lond.)55, 13–19 (2005).
   Google Scholar
• Jason LA, Richman JA, Rademaker AW et al. A community-based study of chronic fatigue syndrome. Arch. Intern. Med.159, 2129–2137 (1999).
   PubMed Web of Science ®Google Scholar
• Reyes M, Nisenbaum R, Hoaglin DC et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch. Intern. Med.163, 1530–1536 (2003).
   PubMed Web of Science ®Google Scholar
• Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff. Resour. Alloc.2, 4 (2004).
   PubMedGoogle Scholar
• Holmes GP, Kaplan JE, Gantz NM et al. Chronic fatigue syndrome: a working case definition. Ann. Intern. Med.108, 387–389 (1988).
   PubMed Web of Science ®Google Scholar
• Lloyd AR, Hickie I, Boughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med. J. Aust.153, 522–528 (1990).
   PubMed Web of Science ®Google Scholar
• Sharpe MC, Archard LC, Banatvala JE et al. A report — chronic fatigue syndrome: guidelines for research. J. R. Soc. Med.84, 12118–12121 (1991).
   Google Scholar
• Fukuda K, Strauss SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med.121, 953–959 (1994).
   PubMed Web of Science ®Google Scholar
• Reeves WC, Lloyd A, Vernon SD et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health. Serv. Res.3, 25 (2003).
   PubMed Web of Science ®Google Scholar
• Carruthers BM, Jain AK, De Meirleir KL et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr.11, 7–116 (2003).
   Google Scholar
• Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum.33, 381–387 (1990).
   PubMed Web of Science ®Google Scholar
• Chakrabarty S, Zoorob R. Fibromyalgia. Am. Fam. Physician.15, 247–254 (2007).
   Google Scholar
• Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann. Intern. Med.146, 726–734 (2007).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum.33, 160–172 (1990).
   PubMed Web of Science ®Google Scholar
• Komaroff AL, Fagioli LR, Geiger AM et al. An examination of the working case definition of chronic fatigue syndrome. Am. J. Med.100, 56–64 (1996).
   PubMed Web of Science ®Google Scholar
• Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin. Rheumatol.26, 465–473 (2007).
   PubMed Web of Science ®Google Scholar
• Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet354, 936–939 (1999).
   PubMed Web of Science ®Google Scholar
• Bradley LA, McKendree-Smith, Alarcon GS. Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr. Rev. Pain.4, 148–157 (2000).
   PubMedGoogle Scholar
• White PD. What causes chronic fatigue syndrome? Br. Med. J.329, 928–929 (2004).
   PubMed Web of Science ®Google Scholar
• Mihrshahi R, Beirman R. Aetiology and pathogenesis of chronic fatigue syndrome: a review. NZ Med. J.118, U1789 (2005).
   Google Scholar
• Papanicolaou DA, Amsterdam JD, Levine S et al. Neuroendocrine aspects of chronic fatigue syndrome. Neuroimmunomodulation11, 65–74 (2004).
   PubMedGoogle Scholar
• Gerrity TR, Papanicolaou DA, Amsterdam JD et al. Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. Neuroimmunomodulation11, 351–357 (2004).
   PubMed Web of Science ®Google Scholar
• Hampton T. Researchers find genetic clues to chronic fatigue syndrome. JAMA295, 2466–2467 (2006).
   PubMed Web of Science ®Google Scholar
• Vernon SD, Reeves WC. The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics7, 345–354 (2006).
   PubMed Web of Science ®Google Scholar
• Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics7, 429–440 (2006).
   PubMed Web of Science ®Google Scholar
• Vernon SD, Whistler T, Aslakson E, Rajeevan M, Reeves WC. Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics7, 211–218 (2006).
   PubMed Web of Science ®Google Scholar
• Lange G, Steffener J, Cook DB et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage26, 513–524 (2005).
   PubMed Web of Science ®Google Scholar
• Michiels V, Cluydts R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr. Scand.103, 84–93 (2001).
   PubMed Web of Science ®Google Scholar
• Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev.24, 236–252 (2003).
   PubMed Web of Science ®Google Scholar
• Chambers D, Bagnall AM, Hempel S, Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J. R. Soc. Med.99, 506–520 (2006).
   PubMed Web of Science ®Google Scholar
• Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramírez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA286, 1360–1368 (2001).
   PubMed Web of Science ®Google Scholar
• Edmons M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane. Database. Syst. Rev.2, CD003200 (2004).
   Google Scholar
• Deluca J, Christodoulou C, Diamond BJ, Rosenstein ED, Kramer N, Natelson BH. Working memory deficits in chronic fatigue syndrome: differentiating between speed and accuracy of information processing. J. Int. Neuropsychol. Soc.10, 101–109 (2004).
   PubMed Web of Science ®Google Scholar
• Busichio K, Tiersky LA, Deluca J, Natelson BH. Neuropsychological deficits in patients with chronic fatigue syndrome. J. Int. Neuropsychol. Soc.10, 278–285 (2004).
   PubMed Web of Science ®Google Scholar
• Marshall PS, Forstot M, Callies A, Peterson PK, Schenck CH. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom. Med.59, 58–66 (1997).
   PubMed Web of Science ®Google Scholar
• Michiels V, de Gucht V, Cluydts R, Fischler B. Attention and information processing efficiency in patients with chronic fatigue syndrome. J. Clin. Exp. Neuropsychol.21, 709–729 (1999).
   PubMed Web of Science ®Google Scholar
• Joyce E, Blumenthal S, Wessely S. Memory, attention, and executive function in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry.60, 495–503 (1996).
   PubMed Web of Science ®Google Scholar
• Michiels V, Cluydts R, Fischler B, Hoffmann G, Le Bon O, De Meirleir K. Cognitive functioning in patients with chronic fatigue syndrome. J. Clin. Exp. Neuropsychol.18, 666–777 (1996).
   PubMed Web of Science ®Google Scholar
• Capuron L, Welberg L, Heim C et al. Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology31, 1777–1784 (2006).
   PubMed Web of Science ®Google Scholar
• Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Curr. Rheumatol. Rep.8, 425–429 (2006).
   PubMedGoogle Scholar
• Abikoff H, Hechtman L, Klein RG et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J. Am. Acad. Child Adolesc. Psychiatry43, 802–811 (2004).
   PubMed Web of Science ®Google Scholar
• Baker K, Barkhuizen A. Pharmacologic treatment of fibromyalgia. Curr. Pain. Headache Rep.9, 301–306 (2005).
   PubMedGoogle Scholar
• Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol. Psychiatry60, 1350–1355 (2006).
   PubMed Web of Science ®Google Scholar
• Schönfeldt-Lecuona C, Connemann BJ, Wolf RC, Braun M, Freudenmann RW. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode. Pharmacopsychiatry39, 152–154 (2006).
   PubMed Web of Science ®Google Scholar
• Olson LG, Ambrogetti A, Sutherland DC. A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics44(1), 38–43 (2003).
   PubMed Web of Science ®Google Scholar
• Lonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum. Psychopharmacol. Clin. Exp.19, 151–180 (2004).
   PubMedGoogle Scholar
• Pietrzak RH, Mollica CM, Maruff P, Snyder PJ. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci. Biobehav. Rev.30, 1225–1245 (2006).
   PubMed Web of Science ®Google Scholar
• Conley R, Gupta SK, Sathyan G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr. Med. Res. Opin.10, 1879–1892 (2006).
   Google Scholar
• Pelham WE, Gnagy EM, Burrows-Maclean L et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics107, E105 (2001).
   PubMedGoogle Scholar
• Wolraich ML, Greenhill LL, Pelham W et al. Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics108, 883–892 (2001).
   PubMed Web of Science ®Google Scholar
• Wilens T, Pelham W, Stein M et al. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J. Am. Acad. Child Adolesc. Psychiatry42, 424–433 (2003).
   PubMed Web of Science ®Google Scholar
• Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled, effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can. J. Clin. Pharmacol.13, E50–E62 (2006).
   PubMedGoogle Scholar
• Posey D, Aman M, McCracken J. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol. Psychiatry61, 538–544 (2007).
   PubMed Web of Science ®Google Scholar
• Bedard AC, Jain U, Johnson SH, Tannock R. Effects of methylphenidate on working memory components: influence of measurement. J. Child. Psychol. Psychiatry.48, 872–880 (2007).
   PubMed Web of Science ®Google Scholar
• Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am. J. Hosp. Palliat. Care.23, 35–40 (2006).
   PubMedGoogle Scholar
• Rozans M, Dreisbach A, Lertora JJ, Kahn MJ. Palliative uses of methylphenidate in patients with cancer: a review. J. Clin. Oncol.20, 335–339 (2002).
   PubMedGoogle Scholar
• Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch. Phys. Med. Rehabil.79, 1047–1050 (1998).
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch. Intern. Med.161, 411–420 (2001).
   PubMedGoogle Scholar
• Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am. J. Med.119, E23–E30 (2006).
   Google Scholar
• Young JL, Redmond JC. Fibromylagia, chronic fatigue, and adult attention deficit hyperactivity disorder in the adult: a case study. Psychopharmacol. Bull.40, 118–126 (2007).
   PubMedGoogle Scholar